The Zambia Medicines Regulatory Authority (ZAMRA) has approved lenacapavir tablets and injectable formulations for HIV prevention, granting authorization on 4 November 2025 after just 12 working days of review. The decision was made using the WHO…
Lenacapavir approved in Zambia and Zimbabwe in record time through WHO Collaborative Registration Procedure
